Patel Akshay J, Josephides Eleni, Bilkhu Rajdeep, Bosco Paolo, Lucchese Gianluca, Bille Andrea
Department of Thoracic Surgery, Guy's Hospital, Guy's and St. Thomas' Hospital NHS Trust, London, UK.
Institute of Immunology and Immunotherapy, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK.
J Thorac Dis. 2025 Jan 24;17(1):299-307. doi: 10.21037/jtd-24-1395. Epub 2025 Jan 22.
Thymic epithelial tumors (TETs) represent the predominant primary malignancy of the anterior mediastinum, often necessitating complex surgical interventions due to their invasive nature. The prognosis of advanced TET relies significantly on achieving complete resection with microscopically clear margins (R0). This frequently entails resection and reconstruction of major vascular structures like the superior vena cava (SVC) and brachiocephalic veins, and in some cases, extra pleural pneumonectomy (EPP). The aim of the study is to interrogate our series of advanced TET resections.
We analysed our experience with vascular resection and reconstruction in 14 patients with advanced stage III/IV TET undergoing extensive resection post-neoadjuvant chemotherapy. A comprehensive preoperative evaluation was performed, including computed tomography (CT), positron emission tomography (PET), biopsy, and exercise testing. We describe our surgical approach and the details of our series.
From 2015 to 2023, 31 patients underwent surgery for advanced TET at our centre, with major vessel reconstruction performed in 14 cases. This included resection of SVC and innominate veins with subsequent reconstruction using polytetrafluoroethylene (PTFE) grafts. The median operative time was 350 minutes, with a median blood loss of 1,300 mL. Cardiopulmonary bypass (CPB) was required in 2 cases. The rate of R0 resection was 78.6%, with a recurrence rate of 14.3% at a median follow-up of 1,700 days. Postoperative complications occurred in 42.9% of patients, with an in-hospital mortality rate of 7.1%.
Multi-disciplinary management, meticulous preoperative planning, and advanced surgical techniques are essential for the successful treatment of advanced TET. Complex vascular resections should be reserved for high-volume centres to optimize outcomes.
胸腺上皮肿瘤(TETs)是前纵隔最主要的原发性恶性肿瘤,因其具有侵袭性,常常需要进行复杂的手术干预。晚期TET的预后很大程度上依赖于实现显微镜下切缘阴性的完整切除(R0)。这通常需要切除并重建诸如上腔静脉(SVC)和头臂静脉等主要血管结构,在某些情况下还需要进行胸膜外全肺切除术(EPP)。本研究的目的是探讨我们一系列晚期TET切除术的情况。
我们分析了14例接受新辅助化疗后进行广泛切除的晚期III/IV期TET患者的血管切除和重建经验。进行了全面的术前评估,包括计算机断层扫描(CT)、正电子发射断层扫描(PET)、活检和运动测试。我们描述了我们的手术方法及系列病例的详细情况。
2015年至2023年,我们中心有31例患者接受了晚期TET手术,其中14例进行了主要血管重建。这包括切除SVC和无名静脉,随后使用聚四氟乙烯(PTFE)移植物进行重建。中位手术时间为350分钟,中位失血量为1300毫升。2例患者需要体外循环(CPB)。R0切除率为78.6%,中位随访1700天时复发率为14.3%。42.9%的患者发生了术后并发症,院内死亡率为7.1%。
多学科管理、细致的术前规划和先进的手术技术对于晚期TET的成功治疗至关重要。复杂的血管切除术应保留给大型中心以优化治疗结果。